PDS Biotechnology to Host KOL Event on PDS0301 Phase 2 mCRC Data
PDS Biotechnology will host a virtual KOL event to discuss PDS0301 Phase 2 clinical outcomes in metastatic colorectal cancer with liver metastases.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.